Napigen logo-full.jpg
NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant
March 11, 2024 08:15 ET | Napigen, Inc.
The USPTO issued a patent to NAPIGEN for the use of CRISPR technologies to edit organellar genomes. Separately, USDA awarded NAPIGEN an SBIR phase 1 grant.
7 Hills Pharma Launc
7 Hills Pharma Launches With $2 Million SBIR Grant in Addition to $4 Million in Seed Capital to Pursue Novel Cancer Therapeutics to Promote a Productive Immune Response and Overcome Drug Resistance
June 19, 2018 08:00 ET | 7 Hills Pharma
HOUSTON, June 19, 2018 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a privately-held immunotherapy company focused on development of novel tumor-targeting cell adhesion agents, announced today that it has...
Amydis_Logo_Horiz_RGB@2x.png
NIH Awards Cerebral Amyloid Angiopathy Grant to Amydis Diagnostics
October 09, 2017 09:14 ET | Amydis Diagnostics, Inc.
SAN DIEGO, Oct. 09, 2017 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative approaches for the detection of...